Reporting adverse events

Erelzi® (etanercept) and Rixathon® (rituximab) are black triangle medications and are subject to additional monitoring.

The safety of our products and the health and well being of our patients are our highest priority. If you would like to report an adverse event involving a Sandoz medicine, please contact our global pharmacovigilance team.

We use cookies to enhance your navigation through this website. To read more about cookies and how to change your browser settings, please click the following link. By clicking on the "Accept" button, we understand that you accept our Cookie Policy.